HUAWEI
28.2.2022 16:39:06 CET | Business Wire | Press release
During the Huawei Day 0 Forum at MWC Barcelona 2022, Huawei released a series of new IT products and solutions as part of a new "intelligent IT foundation" for operators. David Wang, Executive Director of the Board and Chairman of the ICT Infrastructure Managing Board at Huawei, explained in his keynote speech titled "+IT, New Growth" that this reliable and efficient IT foundation will help operators go intelligent, increase revenue, reduce costs, boost efficiency, and ultimately achieve new growth.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220228005736/en/
With the rapid development of emerging technologies like 5G, IoT, cloud computing, and intelligence, operators have put their own digital transformations at the top of their agendas so that they can later help other B2B industries to go digital. This kind of transformation however requires IT infrastructure upgrades, multi-cloud collaboration, and quick market wins to generate more momentum.
Wang explained that Huawei's intelligent IT foundation is specifically designed to help operators meet these new requirements. This foundation includes a fully-collaborative distributed cloud and an all-scenario data pool.
At the same event, Huawei also launched the industry's first ever distributed, cloud-native solution. This fully-collaborative cloud helps operators to achieve ICT orchestration, cloud-network synergy, and cloud-edge synergy. The architecture supports both data and media platforms as a service for operators and application platform as a service (aPaaS) for industry customers. This delivers guaranteed experiences for app users unlimited by geography, multi-cloud collaboration, and data traffic. The company currently says that one day, it hopes to offer everything as a service.
Huawei also announced a new series of data infrastructure products as part of its OneStorage strategy to support continual storage evolution. As data types continue to diversify, applications have become more affordable and data protection is more important than ever. Huawei's OneStorage solution gives operators the efficiency they need to meet these requirements through on-demand resource provisioning, intelligent data management, and multi-cloud convergence. It is currently Huawei's best offering for operators who want to keep their data infrastructure up-to-date and explore new businesses.
By the end of 2021, HUAWEI CLOUD and its partners had built 61 availability zones in 27 areas to serve more than 170 countries and regions. It has also started working with more than 120 operators in the cloud service market to help enterprise customers go digital. It currently offers more than 50 scenario-specific cloud services for nine vertical markets, such as manufacturing, retail, and healthcare, to go digital. These intelligent and efficient data storage services offerings are currently used by 300 operators worldwide and the OceanStor Dorado solution has been named a Leader in Gartner's Magic Quadrant for six years in a row.
Reliable, efficient, and intelligent IT infrastructure is critical for operators to go digital. Huawei wants to continue working with operators to roll out IT infrastructure, help industry go digital, and achieve new growth together.
MWC22 Barcelona will run from February 28 to March 3 in Barcelona, Spain. Huawei will showcase its products and solutions at stand 1H50 in Fira Gran Via Hall 1. Together with global operators, industry professionals, and opinion leaders, we will dive into topics such as industry trends, GUIDE to the Future, and green development to envision the future of digital networks. For more information, please visit: https://carrier.huawei.com/en/events/mwc2022 .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220228005736/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom